Antioxidants in cardiovascular therapy

panacea or false hope?

Katarzyna Goszcz, Sherine J Deakin, Garry G Duthie, Derek Stewart, Stephen J Leslie, Ian L Megson

Research output: Contribution to journalArticle

5 Downloads (Pure)

Abstract

Oxidative stress is a key feature of the atherothrombotic process involved in the etiology of heart attacks, ischemic strokes, and peripheral arterial disease. It stands to reason that antioxidants represent a credible therapeutic option to prevent disease progression and thereby improve outcome, but despite positive findings from in vitro studies, clinical trials have failed to consistently show benefit. The aim of this review is to re-appraise the concept of antioxidants in the prevention and management of cardiovascular disease. In particular, the review will explore the reasons behind failed antioxidant strategies with vitamin supplements and will evaluate how flavonoids might improve cardiovascular function despite bioavailability that is not sufficiently high to directly influence antioxidant capacity. As well as reaching conclusions relating to those antioxidant strategies that might hold merit, the major myths, limitations, and pitfalls associated with this research field are explored.

Original languageEnglish
Article number29
Number of pages22
JournalFrontiers in cardiovascular medicine
Volume2
Early online date6 Jul 2015
DOIs
Publication statusPublished - 2015

Fingerprint

Antioxidants
Therapeutics
Peripheral Arterial Disease
Flavonoids
Vitamins
Biological Availability
Disease Progression
Oxidative Stress
Cardiovascular Diseases
Stroke
Myocardial Infarction
Clinical Trials
Research

Keywords

  • antioxidants
  • vitamin C
  • vitamin E
  • carotenoids
  • polyphenols
  • vascular disease
  • N-acetylcysteine
  • allopurinol

Cite this

Antioxidants in cardiovascular therapy : panacea or false hope? / Goszcz, Katarzyna; Deakin, Sherine J; Duthie, Garry G; Stewart, Derek; Leslie, Stephen J; Megson, Ian L.

In: Frontiers in cardiovascular medicine, Vol. 2, 29, 2015.

Research output: Contribution to journalArticle

Goszcz, Katarzyna ; Deakin, Sherine J ; Duthie, Garry G ; Stewart, Derek ; Leslie, Stephen J ; Megson, Ian L. / Antioxidants in cardiovascular therapy : panacea or false hope?. In: Frontiers in cardiovascular medicine. 2015 ; Vol. 2.
@article{ae51ee7e4236460fbcdd3f213e83ef30,
title = "Antioxidants in cardiovascular therapy: panacea or false hope?",
abstract = "Oxidative stress is a key feature of the atherothrombotic process involved in the etiology of heart attacks, ischemic strokes, and peripheral arterial disease. It stands to reason that antioxidants represent a credible therapeutic option to prevent disease progression and thereby improve outcome, but despite positive findings from in vitro studies, clinical trials have failed to consistently show benefit. The aim of this review is to re-appraise the concept of antioxidants in the prevention and management of cardiovascular disease. In particular, the review will explore the reasons behind failed antioxidant strategies with vitamin supplements and will evaluate how flavonoids might improve cardiovascular function despite bioavailability that is not sufficiently high to directly influence antioxidant capacity. As well as reaching conclusions relating to those antioxidant strategies that might hold merit, the major myths, limitations, and pitfalls associated with this research field are explored.",
keywords = "antioxidants, vitamin C, vitamin E, carotenoids, polyphenols , vascular disease, N-acetylcysteine, allopurinol",
author = "Katarzyna Goszcz and Deakin, {Sherine J} and Duthie, {Garry G} and Derek Stewart and Leslie, {Stephen J} and Megson, {Ian L}",
note = "Date of Acceptance:10/06/2015 Acknowledgments KG’s Ph.D. was funded by the EU North Sea Region Programme (www.ClimaFruit.com), a European Regional Development Fund initiative.",
year = "2015",
doi = "10.3389/fcvm.2015.00029",
language = "English",
volume = "2",
journal = "Frontiers in cardiovascular medicine",
issn = "2297-055X",

}

TY - JOUR

T1 - Antioxidants in cardiovascular therapy

T2 - panacea or false hope?

AU - Goszcz, Katarzyna

AU - Deakin, Sherine J

AU - Duthie, Garry G

AU - Stewart, Derek

AU - Leslie, Stephen J

AU - Megson, Ian L

N1 - Date of Acceptance:10/06/2015 Acknowledgments KG’s Ph.D. was funded by the EU North Sea Region Programme (www.ClimaFruit.com), a European Regional Development Fund initiative.

PY - 2015

Y1 - 2015

N2 - Oxidative stress is a key feature of the atherothrombotic process involved in the etiology of heart attacks, ischemic strokes, and peripheral arterial disease. It stands to reason that antioxidants represent a credible therapeutic option to prevent disease progression and thereby improve outcome, but despite positive findings from in vitro studies, clinical trials have failed to consistently show benefit. The aim of this review is to re-appraise the concept of antioxidants in the prevention and management of cardiovascular disease. In particular, the review will explore the reasons behind failed antioxidant strategies with vitamin supplements and will evaluate how flavonoids might improve cardiovascular function despite bioavailability that is not sufficiently high to directly influence antioxidant capacity. As well as reaching conclusions relating to those antioxidant strategies that might hold merit, the major myths, limitations, and pitfalls associated with this research field are explored.

AB - Oxidative stress is a key feature of the atherothrombotic process involved in the etiology of heart attacks, ischemic strokes, and peripheral arterial disease. It stands to reason that antioxidants represent a credible therapeutic option to prevent disease progression and thereby improve outcome, but despite positive findings from in vitro studies, clinical trials have failed to consistently show benefit. The aim of this review is to re-appraise the concept of antioxidants in the prevention and management of cardiovascular disease. In particular, the review will explore the reasons behind failed antioxidant strategies with vitamin supplements and will evaluate how flavonoids might improve cardiovascular function despite bioavailability that is not sufficiently high to directly influence antioxidant capacity. As well as reaching conclusions relating to those antioxidant strategies that might hold merit, the major myths, limitations, and pitfalls associated with this research field are explored.

KW - antioxidants

KW - vitamin C

KW - vitamin E

KW - carotenoids

KW - polyphenols

KW - vascular disease

KW - N-acetylcysteine

KW - allopurinol

U2 - 10.3389/fcvm.2015.00029

DO - 10.3389/fcvm.2015.00029

M3 - Article

VL - 2

JO - Frontiers in cardiovascular medicine

JF - Frontiers in cardiovascular medicine

SN - 2297-055X

M1 - 29

ER -